Citations

Showing 10 of 108083 citations.

Osseointegration and Bone Resorption of Scapula Tip Free Flaps in Mandibular Reconstruction
Barton, Blair M. , Mamdani, Mohammed, Lumley, Catherine , Blumberg, Jeffrey M. , Patel, Samip , Patel, Samip N , Huang, Benjamin

Mayo Clinic

The Laryngoscope | January 18, 2023 | Volume: 133 | Issue: 10 | Pages: 2597-2602

10.1002/lary.30574 | PMID 36651328 Get It

ObjectivesBone resorption of more conventional vascularized bone grafts have been well described showing minimal resorption over time. Few studies have evaluated osseous union and bone resorption in scapula tip free flaps (STFF) in the reconstruction of mandibulectomy defects. We aimed to describe our series on STFF with respect to osseous union and bone resorption over time.MethodsRetrospective chart review of patients receiving STFF from January 2014–January 2017 (n = 25). A neuroradiologist analyzed follow‐up CT scans to assess (1) STFF complete, partial, or no osseous union with native mandible and (2) STFF volume change over time in a subset with multiple follow‐up scans (n = 18).ResultsTwenty‐three of 25 patients (92%) showed complete or partial STFF osseous union with native mandible either distally or proximally. STFF volume change ranged from +4.8 to −54% (median −0.5%) over median follow‐up interval of 23 months. History of chemoradiation therapy, bisphophonate use, sex, age, or smoking history did not correlate with bone resorption.ConclusionsSTFFs shows high rates of osseous union and limited bone resorption that is equivalent to, or less than, vascularized fibular and iliac crest flaps. Clinically, this translates into both optimal healing and functional and cosmetic outcomes, especially in the setting of prior therapies.Level of Evidence4 Laryngoscope, 133:2597–2602, 2023
Can We Predict Thyroid Eye Disease Occurrence and Progression in Newly Diagnosed Graves’ Disease?
Rachmasari, Kharisa N. , Kawkgi, Omar El

Mayo Clinic

Clinical Thyroidology | January 18, 2023 | Volume: 35 | Issue: 1 | Pages: 9-11

10.1089/ct.2023;35.9-11 Get It

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
Strawn, Jeffrey R. , Mills, Jeffrey A. , Poweleit, Ethan A. , Ramsey, Laura B. , Croarkin, Paul E. , Croarkin, Paul E , Strawn, Jeffrey R

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | January 18, 2023 | Volume: 43 | Issue: 7 | Pages: 675-690

10.1002/phar.2767 | PMID 36651686 Get It

Abstract Introduction Selective serotonin reuptake inhibitors (SSRIs) and, to a lesser extent, serotonin‐norepinephrine reuptake inhibitors (SNRIs) are the cornerstone of pharmacotherapy for children and adolescents with anxiety and depressive disorders. These medications alleviate symptoms and restore function for many youths; however, they are associated with a distinct adverse effect profile, and their tolerability may complicate treatment or lead to discontinuation. Yet, SSRI/SNRI tolerability has received limited attention in the pediatric literature. Methods This review examines the early‐ (e.g., activation, gastrointestinal symptoms, sedation) and late‐emerging (e.g., weight gain) adverse effects of SSRIs and some SNRIs in pediatric patients. Results We provide a framework for discussing SSRI/SNRI tolerability with patients and their families and describe the pharmacologic basis, course, and predictors of adverse events in youth. Strategies to address specific tolerability concerns are presented. For selected adverse events, using posterior simulation of mean differences over time, we describe their course based on Physical Symptom Checklist measures in a prospective, randomized trial of anxious youth aged 7–17 years who were treated with sertraline ( n = 139) or placebo ( n = 76) for 12 weeks in the Child/Adolescent Anxiety Multimodal Study (CAMS). Main Results In CAMS, the relative severity/burden of total physical symptoms ( p < 0.001), insomnia ( p = 0.001), restlessness ( p < 0.001), nausea ( p = 0.002), abdominal pain ( p < 0.001), and dry mouth ( p = 0.024) decreased from baseline over 12 weeks of sertraline treatment, raising the possibility that these symptoms are transient. No significant changes were observed for sweating ( p = 0.103), constipation ( p = 0.241), or diarrhea ( p = 0.489). Finally, we review the antidepressant withdrawal syndrome in children and adolescents and provide guidance for SSRI discontinuation, using pediatric pharmacokinetic models of escitalopram and sertraline—two of the most used SSRIs in youth. Conclusion SSRI/SNRIs are associated with both early‐emerging (often transient) and late‐emerging adverse effects in youth. Pharmacokinetically‐informed appraoches may address some adverse effects and inform SSRI/SNRI discontinuation strategies.
Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response
Engel, Elissa , Hammill, Adrienne M. , Adams, Denise M. , Phillips, Roderic J. , Jeng, Michael , Tollefson, Megha M. , Iacobas, Ionela , Schiff, Deborah , Greenberger, Shoshana , Frieden, Ilona J. , Zaghloul, Nibal, Drolet, Beth A. , Geddis, Amy E., Engel, Elissa R , Hammill, Adrienne , Ricci, Kiersten , Jeng, Michael , Kelly, Michael , Goldenberg, Dov Charles

Mayo Clinic

Pediatric Blood & Cancer | January 18, 2023 | Volume: 70 | Issue: 4 | Pages: No page available

10.1002/pbc.30215 | PMID 36651691 Get It

Abstract Background Capillary lymphatic venous malformations (CLVM) and associated syndromes, including Klippel–Trenaunay syndrome (KTS) and congenital lipomatous overgrowth, vascular malformation, epidermal nevi, skeletal, and spinal syndrome (CLOVES), are underrecognized disorders associated with high morbidity from chronic pain, recurrent infections, bleeding, and clotting complications. The rarity of these disorders and heterogeneity of clinical presentations make large‐scale randomized clinical drug trials challenging. Identification of PIK3CA (phosphatidylinositol‐4,5‐bisphosphate 3‐kinase catalytic subunit alpha [gene]) mutations in CLVM has made targeted medications, such as sirolimus, attractive treatment options. The aim of this study was to investigate the safety and efficacy of sirolimus therapy in CLVM. Procedure A combined prospective and retrospective cohort of pediatric and young adult patients with CLVM treated with sirolimus was evaluated for disease response, including symptom improvement, quality of life (QOL), and radiologic response. Sirolimus dosing regimens and toxicities were also assessed. Results Twenty‐nine patients with CLVM, including KTS and CLOVES, were included. Ninety‐three percent of patients reported improved QOL, and 86% had improvement in at least one symptom. Most significantly, improvement was noted in 100% of patients with bleeding and 89% with thrombotic complications with corresponding decreases in mean D‐dimer ( p = .008) and increases in mean fibrinogen ( p = .016). No patients had progressive disease on sirolimus. Most common side effects included neutropenia, lymphopenia, infection, and aphthous ulcers/stomatitis. No toxicities were life‐threatening, and none required long‐term discontinuation of sirolimus. Conclusion Sirolimus appears to be effective at reducing complications and improving QOL in patients with CLVM and associated syndromes. In this patient cohort, sirolimus was well tolerated and resulted in few treatment‐related toxicities.
Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer
Kaplan, Jamie L. , Türker, İsmail , Chumsri, Saranya , Turker, Ismail, Gabriel, Emmanuel

Mayo Clinic

Frontiers in Bioscience-Scholar | January 18, 2023 | Volume: 15 | Issue: 1 | Pages: No page available

10.31083/j.fbs1501002 | PMID 36959110 Get It

While breast cancer is a common disease with many available treatment options, many patients still have limited responses, especially those with metastatic breast cancer. Surgery of the primary tumor or metastatic sites is often not part of the treatment regimen for patients with metastatic breast cancer. Cryoablation is a relatively non-invasive procedure that is being investigated for patients with breast cancer. Patients with metastatic breast cancer who are not surgical candidates may derive benefit from cryoablation through the abscopal effect. In this case report, we present a patient with stage IV breast cancer who was treated with cryoablation of the primary breast tumor and showed evidence of an abscopal effect in regional and distant metastases.
Determining the cause of cardiac arrest: artificial intelligence at the bedside
Engrav, Samantha K. , Geske, Jeffrey B. , Siontis, Konstantinos C. , Geske, Jeffrey B

Mayo Clinic

European Heart Journal - Digital Health | January 18, 2023 | Volume: 4 | Issue: 2 | Pages: 136-137

10.1093/ehjdh/ztad002 | PMID 36974266 Get It

Developing multivariable models for predicting headache improvement in patients with acute post‐traumatic headache attributed to mild traumatic brain injury: A preliminary study
Mao, Lingchao, Ku, Dohyun , Ross, Katherine , Li, Jing , Chong, Catherine D. , Mao, Lingchao , Chong, Catherine D , Mao, Lingchao , Dumkrieger, Gina , Berisha, Visar , Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | January 18, 2023 | Volume: 63 | Issue: 1 | Pages: 136-145

10.1111/head.14450 | PMID 36651586 Get It

Abstract Objectives/Background Post‐traumatic headache (PTH) is a common symptom after mild traumatic brain injury (mTBI). Although there have been several studies that have used clinical features of PTH to attempt to predict headache recovery, currently no accurate methods exist for predicting individuals’ improvement from acute PTH. This study investigated the utility of clinical questionnaires for predicting (i) headache improvement at 3 and 6 months, and (ii) headache trajectories over the first 3 months. Methods We conducted a clinic‐based observational longitudinal study of patients with acute PTH who completed a battery of clinical questionnaires within 0–59 days post‐mTBI. The battery included headache history, symptom evaluation, cognitive tests, psychological tests, and scales assessing photosensitivity, hyperacusis, insomnia, cutaneous allodynia, and substance use. Each participant completed a web‐based headache diary, which was used to determine headache improvement. Results Thirty‐seven participants with acute PTH (mean age = 42.7, standard deviation [SD] = 12.0; 25 females/12 males) completed questionnaires at an average of 21.7 (SD = 13.1) days post‐mTBI. The classification of headache improvement or non‐improvement at 3 and 6 months achieved cross‐validation area under the curve (AUC) of 0.72 (95% confidence interval [CI] 0.55 to 0.89) and 0.84 (95% CI 0.66 to 1.00). Sub‐models trained using only the top five features still achieved 0.72 (95% CI 0.55 to 0.90) and 0.77 (95% CI 0.52 to 1.00) AUC. The top five contributing features were from three questionnaires: Pain Catastrophizing Scale total score and helplessness sub‐domain score; Sports Concussion Assessment Tool Symptom Evaluation total score and number of symptoms; and the State‐Trait Anxiety Inventory score. The functional regression model achieved for modeling headache trajectory over the first 3 months. Conclusion Questionnaires completed following mTBI have good utility for predicting headache improvement at 3 and 6 months in the future as well as the evolving headache trajectory. Reducing the battery to only three questionnaires, which assess post‐concussive symptom load and biopsychosocialecologic factors, was helpful to determine a reasonable prediction accuracy for headache improvement.
Experience and Attitudes Toward Telehealth in Student-Run Free Clinics (SRFC)
Luong, Hanna N. , Shahin, Ahmad , Porter, Katherine R., Chavez, Augustine , Shahin, Ahmad B

Mayo Clinic

Journal of Primary Care & Community Health | January 18, 2023 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/21501319221148795 | PMID 36651590 Get It

Introduction/Objectives: Telehealth services expanded during the coronavirus disease 2019 (COVID-19) pandemic. Student-run free clinics (SRFC) deliver important health care services to underserved populations, who may face barriers to telehealth use. This study characterizes telehealth usage, experiences, and attitudes among individuals working in SRFCs. Methods: In November 2021, a survey adapted from the COVID-19 Healthcare Coalition Telehealth Impact Physician Survey was sent to all registrants who identified themselves as students at the 2020 Society of Student-Run Free Clinics Annual Conference. Results: Thirty-eight individuals of 576 registrants (7%) representing 21 of 88 (24%) SRFCs completed the survey. Twenty-one (58%) individuals reported using telehealth in their clinic. Those that did not cited lack of infrastructure as a barrier (eg, broadband, Internet challenges, technology investments), were more likely to serve homeless (P = .01), and less likely to serve non-English speaking populations (P = .02). There were increases in telehealth and decreases in in-person visits after March 11, 2020 though changes did not reach statistical significance. At least 15 (68%) wanted to continue chronic disease management, preventative care, and mental/behavioral health via telehealth after COVID-19. Most felt that telehealth was easy to use and improved the health, safety, and timeliness of care of patients, but not work satisfaction or access to care. Difficulty accessing physical devices, Internet, and data was the most-cited barrier to maintaining and accessing telehealth. Conclusions: Nearly all participants cited significant benefits and barriers to telehealth that impacted perceived access to care and sustainability. SRFCs’ experiences may be modulated by their underserved populations and role in student education. Addressing barriers, particularly patient- and clinic-level technology challenges, could work to improve inequities in telehealth uptake.
Thalamic subfield iron accumulation after acute mild traumatic brain injury as a marker of future post‐traumatic headache intensity
Chong, Catherine D. , Nikolova, Simona , Li, Jing , Ross, Katherine , Chong, Catherine D , Dumkrieger, Gina , Wu, Teresa , Berisha, Visar , Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | January 18, 2023 | Volume: 63 | Issue: 1 | Pages: 156-164

10.1111/head.14446 | PMID 36651577 Get It

Abstract Objective To explore alterations in thalamic subfield volume and iron accumulation in individuals with post‐traumatic headache (PTH) relative to healthy controls. Background The thalamus plays a pivotal role in the pathomechanism of pain and headache, yet the role of the thalamus in PTH attributed to mild traumatic brain injury (mTBI) remains unclear. Methods A total of 107 participants underwent multimodal T1‐weighted and T2* brain magnetic resonance imaging. Using a clinic‐based observational study, thalamic subfield volume and thalamic iron accumulation were explored in 52 individuals with acute PTH (mean age = 41.3; standard deviation [SD] = 13.5), imaged on average 24 days post mTBI, and compared to 55 healthy controls (mean age = 38.3; SD = 11.7) without history of mTBI or migraine. Symptoms of mTBI and headache characteristics were assessed at baseline (0–59 days post mTBI) ( n = 52) and 3 months later ( n = 46) using the Symptom Evaluation of the Sports Concussion Assessment Tool (SCAT‐5) and a detailed headache history questionnaire. Results Relative to controls, individuals with acute PTH had significantly less volume in the lateral geniculate nucleus (LGN) (mean volume: PTH = 254.1, SD = 43.4 vs. controls = 278.2, SD = 39.8; p = 0.003) as well as more iron deposition in the left LGN (PTH: T2* signal = 38.6, SD = 6.5 vs. controls: T2* signal = 45.3, SD = 2.3; p = 0.048). Correlations in individuals with PTH revealed a positive relationship between left LGN T2* iron deposition and SCAT‐5 symptom severity score at baseline ( r = −0.29, p = 0.019) and maximum headache intensity at the 3‐month follow‐up ( r = −0.47, p = 0.002). Conclusion Relative to healthy controls, individuals with acute PTH had less volume and higher iron deposition in the left LGN. Higher iron deposition in the left LGN might reflect mTBI severity and poor headache recovery.
Macrophages and Bone Remodeling
Weivoda, Megan , Bradley, Elizabeth W. , Weivoda, Megan M, Bradley, Elizabeth W

Mayo Clinic

Journal of Bone and Mineral Research | January 18, 2023 | Volume: 38 | Issue: 3 | Pages: 359-369

10.1002/jbmr.4773 | PMID 36651575 Get It

ABSTRACT Bone remodeling in the adult skeleton facilitates the removal and replacement of damaged and old bone to maintain bone quality. Tight coordination of bone resorption and bone formation during remodeling crucially maintains skeletal mass. Increasing evidence suggests that many cell types beyond osteoclasts and osteoblasts support bone remodeling, including macrophages and other myeloid lineage cells. Herein, we discuss the origin and functions for macrophages in the bone microenvironment, tissue resident macrophages, osteomacs, as well as newly identified osteomorphs that result from osteoclast fission. We also touch on the role of macrophages during inflammatory bone resorption. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).